HOME > ARCHIVE
ARCHIVE
- Banyu Aims to Boost Nu-Lotan's Market Share to 30%
January 12, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 12, 2004
- IMS Japan Aims to Become a Services-based Company: President Saeki
January 12, 2004
- ON THE MOVE
January 12, 2004
- Time to New Drug Approval Down Sharply Since Mid-90s: OPIR
January 12, 2004
- Test Kit to Be Developed to Predict Effects of Morphine
January 12, 2004
- BUSINESS NEWS IN BRIEF
January 12, 2004
- RA Patients Criticized as Selfish, Lazy: Wyeth Survey
January 12, 2004
- BULLETIN
January 12, 2004
- Pharmacokinetic Frequency Analysis Database Jointly Developed by PSC, JBIC
January 12, 2004
- Surprise-Free 2004 Predictions
December 29, 2003
- Sales of 350 OTC Drug Products to Be Deregulated
December 29, 2003
- Sales of Fujisawa's Funguard Well Ahead of Initial Forecast
December 29, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 29, 2003
- Sales of GE Pravastatin Having Difficulties: Elmed Eisai
December 29, 2003
- PRESS SEMINAR
December 29, 2003
- Kuraya Sanseido to Merge with ATOL, Everlth to Form MEDICEO
December 29, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 29, 2003
- Wholesalers' Profits May Fall 30% This Fiscal Year: Mr Kimura of CR&C
December 29, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 29, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
